Related Experiment Video
Updated: Mar 29, 2026

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
Published on: September 20, 2024
Genetics of Sarcoidosis
Tasha E Fingerlin1, Nabeel Hamzeh2, Lisa A Maier2
1National Jewish Health, 1400 Jackson Street, Denver, CO 80206, USA.
Genetic factors influence sarcoidosis presentation, but the extent is unknown. The HLA region is a key genetic risk factor, suggesting an immune response to environmental triggers.
Area of Science:
- Immunology
- Genetics
- Rheumatology
Background:
- Sarcoidosis exhibits significant variability in clinical presentation and disease progression.
- Genetic factors are hypothesized to influence sarcoidosis phenotypes, but the contribution of genetics remains unquantified.
- The Human Leukocyte Antigen (HLA) region is consistently linked to sarcoidosis susceptibility, indicating an immunologic basis.
Purpose of the Study:
- To investigate the role of genetic variation in the variable presentation and progression of sarcoidosis.
- To understand the extent to which genetic factors drive observed phenotypic variability in sarcoidosis.
Main Methods:
- The abstract does not specify the methods used.
- Further research is needed to identify specific genetic variants and their functional roles.
Main Results:
- The precise contribution of genetic factors to sarcoidosis variability is currently unknown.
- The HLA region is the most significant genetic risk factor identified to date.
- Sarcoidosis is considered an exposure-mediated immunologic disease.
Conclusions:
- While the HLA region is a known risk factor, much of the genetic etiology of sarcoidosis remains to be elucidated.
- Identifying specific risk variants, their biological functions, and interactions with environmental exposures is crucial for understanding sarcoidosis pathogenesis.
More Related Videos
Related Concept Videos
Incomplete Dominance
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
Pedigree Analysis
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters

